About the Labs
The Medical Genetics Laboratories at Baylor College of Medicine have been dedicated to providing the medical genetics community with high quality comprehensive diagnostic services for over 40 years. By building on our institution’s strengths in research and discovery, we aim to provide quality genetic testing services relevant to twenty-first century medicine. Some of the services include: High Resolution Chromosome Analysis, FISH, Chromosomal Microarray Analysis (CMA), analyte and enzyme testing, DNA based testing, and mitochondrial and metabolic molecular testing.
The Cancer Genetics Laboratory (CGL) is a combined effort of multiple departments at Baylor College of Medicine. The CGL provides complete and comprehensive whole genome/exome and single gene analysis for oncology. We offer next generation sequencing panels and cancer exome sequencing for mutation analysis, along with conventional single gene assays like deletion/duplication testing, traditional chromosome analysis, FISH testing, and chromosomal microarray analysis (CMA) for copy number analysis. The CGL provides cancer diagnostic testing services for both pediatric and adult cancer. The CGL offers a wide array of tests, rapid turnaround times, and comprehensive data interpretation by faculty and laboratory directors skilled in cancer genetics. Further, we offer competitive pricing and access to insurance coverage through all major commercial insurance carriers and most small carriers as well as Medicare.
The Whole Genome Laboratory (WGL) derives from a joint effort by Baylor's Human Genome Sequencing Center and the Medical Genetics Laboratories of the Department of Molecular and Human Genetics to establish a clinical laboratory dedicated to state-of-the-art next generation sequencing. The collaboration between these groups brings together genomic scientists, clinical laboratory scientists, and clinicians to provide reliable genome-wide analyses that are carefully annotated and interpreted for clinical significance by medical geneticists. Whole Exome Sequencing is the first test to be offered and is focused on the evaluation of underlying genetic causes of disease. In the near future, the WGL will implement additional clinical tests, including Whole Genome Sequencing (WGS) that will bring this technology to other aspects of medical care and treatment.